{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:07:24Z","timestamp":1761743244155},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T00:00:00Z","timestamp":1249344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s11255-009-9625-y","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T09:24:54Z","timestamp":1249291494000},"page":"211-218","source":"Crossref","is-referenced-by-count":3,"title":["The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients"],"prefix":"10.1007","volume":"42","author":[{"given":"Sibel","family":"Ertek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Nur","family":"Torun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Ates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"9625_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139X.2003.16025.x","volume":"16","author":"A Levin","year":"2003","unstructured":"Levin A (2003) Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 16:101\u2013105","journal-title":"Semin Dial"},{"key":"9625_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1525-139X.1999.00006.x","volume":"12","author":"MJ Sarnak","year":"1999","unstructured":"Sarnak MJ, Levey AS (1999) Epidemiology of cardiac disease in dialysis patients. Semin Dial 12:69\u201376","journal-title":"Semin Dial"},{"key":"9625_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1525-139X.2008.00457.x","volume":"21","author":"A Remppis","year":"2008","unstructured":"Remppis A, Ritz E (2008) Cardiac problems in the dialysis patient: beyond coronary disease. Semin Dial 21:319\u2013325","journal-title":"Semin Dial"},{"key":"9625_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/138920007779315008","volume":"8","author":"W Herrmann","year":"2007","unstructured":"Herrmann W, Herrmann M, Obeid R (2007) Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 8:17\u201331","journal-title":"Curr Drug Metab"},{"key":"9625_CR5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R Clarke","year":"1991","unstructured":"Clarke R, Daly L, Robinson K et al (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149\u20131155","journal-title":"N Engl J Med"},{"key":"9625_CR6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","volume":"354","author":"GJ Hankey","year":"1999","unstructured":"Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407\u2013413","journal-title":"Lancet"},{"key":"9625_CR7","first-page":"230","volume":"40","author":"B Hultberg","year":"1993","unstructured":"Hultberg B, Andersson A, Sterner G (1993) Plasma homocysteine in renal failure. Clin Nephrol 40:230\u2013234","journal-title":"Clin Nephrol"},{"key":"9625_CR8","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1046\/j.1523-1755.1999.00378.x","volume":"55","author":"A Moustapha","year":"1999","unstructured":"Moustapha A, Gupta A, Robinson K et al (1999) Prevalance and determinants of hyper-homocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 55:1470\u20131475","journal-title":"Kidney Int"},{"key":"9625_CR9","first-page":"S72","volume":"41","author":"P Chauveau","year":"1993","unstructured":"Chauveau P, Chadefaux B, Coude M et al (1993) Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int Suppl 41:S72\u2013S77","journal-title":"Kidney Int Suppl"},{"key":"9625_CR10","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","volume":"94","author":"K Robinson","year":"1996","unstructured":"Robinson K, Gupta A, Dennis V et al (1996) Hyper-homocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743\u20132748","journal-title":"Circulation"},{"key":"9625_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/ajkd.2001.25197","volume":"38","author":"M Fodinger","year":"2001","unstructured":"Fodinger M, Buchmayer H, Heinz G et al (2001) Association of two MTHFR polymorphisms with total homcysteine plasma levels in dialysis patients. Am J Kidney Dis 38:77\u201384","journal-title":"Am J Kidney Dis"},{"key":"9625_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000046313","volume":"90","author":"K Morimoto","year":"2002","unstructured":"Morimoto K, Haneda T, Okamoto K, Ishida H, Kikuchi K (2002) Methylene-tetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients. Nephon 90:43\u201350","journal-title":"Nephon"},{"key":"9625_CR13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11255-008-9379-y","volume":"40","author":"S Gelev","year":"2008","unstructured":"Gelev S, Spasovski G, Dzikova S, Trajkovski Z, Damjanovski G, Amitov V, Sikole A (2008) Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice? Int Urol Nephrol 40:763\u2013770 (Epub 2008 Jun 27)","journal-title":"Int Urol Nephrol"},{"key":"9625_CR14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11255-008-9504-y","volume":"41","author":"H Kocak","year":"2009","unstructured":"Kocak H, Gumuslu S, Sahin E et al (2009) Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in peritoneal dialysis patients. Int Urol Nephrol 41:409\u2013416 (Epub 2008 Dec 30)","journal-title":"Int Urol Nephrol"},{"key":"9625_CR15","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.99.18.2434","volume":"99","author":"J Blacher","year":"1999","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434\u20132439","journal-title":"Circulation"},{"issue":"25 Suppl 1","key":"9625_CR16","first-page":"IV31","volume":"109","author":"JN Cohn","year":"2004","unstructured":"Cohn JN, Quyyumi AA, Holberg NK, Jamerson KA (2004) Surrogate markers for cardiovascular disease: functional markers. Circulation 109(25 Suppl 1):IV31\u2013IV46","journal-title":"Circulation"},{"key":"9625_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.1990.19","volume":"37","author":"GM London","year":"1990","unstructured":"London GM, Marchais SJ, Safar ME, Genest AP, Metivier F, Chedid K, London AM (1990) Aortic and large artery compliance in end-stage renal disease. Kidney Int 37:137\u2013142","journal-title":"Kidney Int"},{"key":"9625_CR18","first-page":"303","volume":"5","author":"D Du Bois","year":"1989","unstructured":"Du Bois D, Du Bois EF (1989) A formula to estimate the approximate surface area if height and weight be known.1916. Nutrition 5:303\u2013311","journal-title":"Nutrition"},{"key":"9625_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"9625_CR20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1023\/A:1005321225893","volume":"20","author":"H Refsum","year":"1997","unstructured":"Refsum H, Fisherstrand T, Guttormsen AB, Ueland PM (1997) Assessment of homocyteine status. J Inherit Metab Dis 20:286\u2013294","journal-title":"J Inherit Metab Dis"},{"key":"9625_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jcp.51.3.183","volume":"51","author":"RA Still","year":"1998","unstructured":"Still RA, McDowell IF (1998) Clinical implications of plasma homocysteine measurement in cardiovascular disease. J Clin Pathol 51:183\u2013188","journal-title":"J Clin Pathol"},{"key":"9625_CR22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","volume":"58","author":"DJ Sahn","year":"1978","unstructured":"Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) The committee on M-mode standardization of the American society of echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072\u20131083","journal-title":"Circulation"},{"key":"9625_CR23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1681\/ASN.V104891","volume":"10","author":"AG Bostom","year":"1999","unstructured":"Bostom AG, Culleton BF (1999) Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 10:891\u2013900","journal-title":"J Am Soc Nephrol"},{"key":"9625_CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1191\/1358863x04vm542oa","volume":"9","author":"C Chrysohoou","year":"2004","unstructured":"Chrysohoou C, Panagiotakos DB, Pitsavos C et al (2004) The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease free people: the \u2018ATTICA\u2019 study. Vasc Med 9:117\u2013123","journal-title":"Vasc Med"},{"key":"9625_CR25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1515\/CCLM.2004.072","volume":"42","author":"A Sobczak","year":"2004","unstructured":"Sobczak A, Wardas W, Zielinska-Danch W, Pawlicki K (2004) The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers. Clin Chem Lab Med 42:408\u2013414","journal-title":"Clin Chem Lab Med"},{"key":"9625_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1291\/hypres.29.403","volume":"29","author":"J Tayama","year":"2006","unstructured":"Tayama J, Munakata M, Yoshinaga K, Toyota T (2006) Higher plasma homocysteine concentration ia associated with more advanced ischemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens Res 29:403\u2013409","journal-title":"Hypertens Res"},{"key":"9625_CR27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1742-1241.2004.00013.x","volume":"58","author":"E Coban","year":"2004","unstructured":"Coban E, Ozdogan M, ErmiS C (2004) Plasma levels of homocysteine in patients with white-coat hypertension. Int J Clin Pract 58:997\u2013999","journal-title":"Int J Clin Pract"},{"key":"9625_CR28","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1515\/CCLM.2003.216","volume":"41","author":"CD Stehouwer","year":"2003","unstructured":"Stehouwer CD, van Guldener C (2003) Does homocysteine cause hypertension? Clin Chem Lab Med 41:1408\u20131411","journal-title":"Clin Chem Lab Med"},{"key":"9625_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cccn.2004.05.006","volume":"348","author":"Y Aso","year":"2004","unstructured":"Aso Y, Yoshida N, Okumura K et al (2004) Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Clin Chim Acta 348:139\u2013145","journal-title":"Clin Chim Acta"},{"key":"9625_CR30","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2005.01364.x","volume":"3","author":"SR Lentz","year":"2005","unstructured":"Lentz SR (2005) Mechanisms of homcysteine induced atherothrombosis. J Thromb Haemost 3:1646\u20131654","journal-title":"J Thromb Haemost"},{"key":"9625_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/CCLM.2007.021","volume":"45","author":"AC Peeters","year":"2007","unstructured":"Peeters AC, van Aken BE, Blom HJ, Reitsma PH (2007) den Heijer M (2007) The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers. Clin Chem Lab Med 45:47\u201353","journal-title":"Clin Chem Lab Med"},{"key":"9625_CR32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2362.2006.01639.x","volume":"36","author":"GH Schernthaner","year":"2006","unstructured":"Schernthaner GH, Plank C, Minar E, Bieglmayer C, Koppensteiner R (2006) Schernthaner G (2006) No effect of homocysteine lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36:333\u2013339","journal-title":"Eur J Clin Invest"},{"key":"9625_CR33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000045664","volume":"85","author":"D McGregor","year":"2000","unstructured":"McGregor D, Shand B, Lynn K (2000) A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron 85:215\u2013220","journal-title":"Nephron"},{"key":"9625_CR34","first-page":"242","volume":"23","author":"VD Alvares Delfino","year":"2007","unstructured":"Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T (2007) Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutiriton 23:242\u2013247","journal-title":"Nutiriton"},{"key":"9625_CR35","first-page":"778","volume":"41","author":"S Hirose","year":"1999","unstructured":"Hirose S, Kono R, Mitarai T, Isoda K, Kim S, Shimoyama H (1999) Hyper-homocysteinemia in CAPD patients: peritoneal transport of total homocysteine at peritoneal equilibration test and daily elimination of total homocysteine. Nippon Jinzo Gakkai Shi 41:778\u2013786","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"9625_CR36","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1046\/j.1523-1755.1999.00437.x","volume":"55","author":"A Vychytil","year":"1999","unstructured":"Vychytil A, Fodinger M, Papagiannopoulos M, W\u00f6lfl G, H\u00f6rl WH, Sunder-Plassmann G (1999) Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients. Kidney Int 55:2054\u20132061","journal-title":"Kidney Int"},{"key":"9625_CR37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1681\/ASN.V72198","volume":"7","author":"DN Churchill","year":"1996","unstructured":"Churchill DN, Taylor DW, Keshaviah PR, The Canada-USA (CANUSA) Peritoneal Dialysis Study Group (1996) Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 7:198\u2013207","journal-title":"J Am Soc Nephrol"},{"key":"9625_CR38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/089686080002000630","volume":"20","author":"DW Johnson","year":"2000","unstructured":"Johnson DW, Kay TD, Vesey DA, Isbel N, Campbell SB, Hawley CM (2000) Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients. Perit Dial Int 20:766\u2013771","journal-title":"Perit Dial Int"},{"key":"9625_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI118776","volume":"98","author":"J Loscalzo","year":"1996","unstructured":"Loscalzo J (1996) The oxidant stress of hyperhomocysteinemia. J Clin Invest 98:5\u20137","journal-title":"J Clin Invest"},{"key":"9625_CR40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/1358863x04vm538oa","volume":"9","author":"K Sydow","year":"2004","unstructured":"Sydow K, Hornig B, Arakawa N et al (2004) Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. Vasc Med 9:93\u2013101","journal-title":"Vasc Med"},{"key":"9625_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.ATV.0000149674.62430.e7","volume":"25","author":"M Cesari","year":"2005","unstructured":"Cesari M, Zanchetta M, Burlina A et al (2005) Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol 25:115\u2013121","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9625_CR42","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","volume":"37","author":"S Laurent","year":"2001","unstructured":"Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236\u20131241","journal-title":"Hypertension"},{"key":"9625_CR43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.ATV.18.4.535","volume":"18","author":"J Blacher","year":"1998","unstructured":"Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM (1998) Influence of biochemical alterations on arterial stifness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18:535\u2013541","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9625_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1440-1797.2004.00242.x","volume":"9","author":"S Zoungas","year":"2004","unstructured":"Zoungas S, Branley P, Kerr PG et al (2004) Aterosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) 9:130\u2013141","journal-title":"Nephrology (Carlton)"},{"key":"9625_CR45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.HYP.34.4.837","volume":"34","author":"LA Bortolotto","year":"1999","unstructured":"Bortolotto LA, Safar ME, Billaud E et al (1999) Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 34:837\u2013842","journal-title":"Hypertension"},{"key":"9625_CR46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2004.07.001","volume":"177","author":"JV Woodside","year":"2004","unstructured":"Woodside JV, McMahon R, Gallagher AM et al (2004) Total homocysteine is not a determinant of arterial pulse wave velocity in young healthy adults. Atherosclerosis 177:337\u2013344","journal-title":"Atherosclerosis"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-009-9625-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9625-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T08:16:31Z","timestamp":1633767391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-009-9625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9625"],"URL":"https:\/\/doi.org\/10.1007\/s11255-009-9625-y","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,4]]}}}